CheXT

CheXT integrates a radiomics-guided global-local transformer to perform weakly supervised localization and classification of cardiopulmonary pathologies in chest X-rays using radiomic features and image-level disease labels.


Key Features:

  • Radiomics-Guided Transformer (RGT) Architecture: A dual-branch architecture that synergizes global image information with local radiomics-guided auxiliary data.
  • Image Transformer Branch: Uses self-attention mechanisms to extract image features and propose bounding boxes for pathology localization.
  • Radiomics Transformer Branch: Processes computed radiomic features extracted from the proposed regions.
  • Fusion Layers: Aggregates information from both image and radiomic branches to integrate diverse data sources.
  • Cross-Attention Mechanism: Implements cross-attention layers to enable interaction between learned image and radiomic features using only image-level disease labels.
  • End-to-End Feedback Loop: Provides iterative refinement of pathology localization without requiring explicit bounding box annotations.

Scientific Applications:

  • Disease Localization: Weakly supervised localization of cardiopulmonary pathologies in chest X-rays.
  • Disease Classification: Improved chest X-ray disease classification by integrating domain-specific radiomic features with image features.

Methodology:

CheXT implements a Radiomics-Guided Transformer with Image and Radiomics Transformer branches employing self-attention, cross-attention, fusion layers, and an end-to-end feedback loop, and is trained on the NIH ChestXRay dataset.

Topics

Details

License:
Not licensed
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python
Added:
12/21/2022
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Publications

Han Y, Holste G, Ding Y, Tewfik A, Peng Y, Wang Z. Radiomics-Guided Global-Local Transformer for Weakly Supervised Pathology Localization in Chest X-Rays. IEEE Transactions on Medical Imaging. 2023;42(3):750-761. doi:10.1109/tmi.2022.3217218. PMID:36288235. PMCID:PMC10081959.

PMID: 36288235
Funding: - National Library of Medicine: 4R00LM013001 - National Science Foundation: 2145640